CVE:PTQ

Protech Home Medical Competitors

C$2.17
-0.10 (-4.41 %)
(As of 04/13/2021 03:59 PM ET)
Add
Compare
Today's Range
C$2.16
Now: C$2.17
C$2.25
50-Day Range
C$1.93
MA: C$2.17
C$2.45
52-Week Range
C$0.77
Now: C$2.17
C$2.54
Volume343,491 shs
Average Volume481,776 shs
Market CapitalizationC$244.92 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Protech Home Medical (CVE:PTQ) Vs. VMD, TMD, HTL, HSM, PHM, and ASG

Should you be buying PTQ stock or one of its competitors? Companies in the industry of "medical devices" are considered alternatives and competitors to Protech Home Medical, including Viemed Healthcare (VMD), Titan Medical (TMD), Hamilton Thorne (HTL), Helius Medical Technologies (HSM), Protech Home Medical (PHM), and Aurora Spine (ASG).

Protech Home Medical (CVE:PTQ) and Viemed Healthcare (TSE:VMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Protech Home Medical and Viemed Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical00503.00
Viemed Healthcare01002.00

Protech Home Medical presently has a consensus target price of C$2.58, indicating a potential upside of 19.05%. Given Protech Home Medical's stronger consensus rating and higher possible upside, equities analysts clearly believe Protech Home Medical is more favorable than Viemed Healthcare.

Profitability

This table compares Protech Home Medical and Viemed Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Viemed HealthcareN/AN/AN/A

Earnings & Valuation

This table compares Protech Home Medical and Viemed Healthcare's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$82.22 million2.98C$-5,417,568.00C($0.05)-45.21
Viemed HealthcareC$131.31 million3.77C$38.69 millionC$0.9812.79

Viemed Healthcare has higher revenue and earnings than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Summary

Viemed Healthcare beats Protech Home Medical on 5 of the 8 factors compared between the two stocks.

Protech Home Medical (CVE:PTQ) and Titan Medical (TSE:TMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Protech Home Medical and Titan Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical00503.00
Titan Medical0000N/A

Protech Home Medical presently has a consensus target price of C$2.58, indicating a potential upside of 19.05%. Given Protech Home Medical's higher possible upside, equities analysts clearly believe Protech Home Medical is more favorable than Titan Medical.

Profitability

This table compares Protech Home Medical and Titan Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Titan MedicalN/AN/AN/A

Earnings & Valuation

This table compares Protech Home Medical and Titan Medical's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$82.22 million2.98C$-5,417,568.00C($0.05)-45.21
Titan MedicalC$20 million11.66C$-39,538,525.00C($0.36)-5.90

Protech Home Medical has higher revenue and earnings than Titan Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Protech Home Medical beats Titan Medical on 5 of the 7 factors compared between the two stocks.

Protech Home Medical (CVE:PTQ) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, earnings, dividends and analyst recommendations.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Protech Home Medical and Hamilton Thorne, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical00503.00
Hamilton Thorne00403.00

Protech Home Medical currently has a consensus target price of C$2.58, indicating a potential upside of 19.05%. Hamilton Thorne has a consensus target price of C$1.87, indicating a potential upside of 10.00%. Given Protech Home Medical's higher possible upside, research analysts plainly believe Protech Home Medical is more favorable than Hamilton Thorne.

Profitability

This table compares Protech Home Medical and Hamilton Thorne's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Hamilton ThorneN/AN/AN/A

Earnings and Valuation

This table compares Protech Home Medical and Hamilton Thorne's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$82.22 million2.98C$-5,417,568.00C($0.05)-45.21
Hamilton ThorneC$38.36 million5.84C$922,803.00C$0.01242.86

Hamilton Thorne has lower revenue, but higher earnings than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.

Helius Medical Technologies (TSE:HSM) and Protech Home Medical (CVE:PTQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Analyst Ratings

This is a summary of current ratings for Helius Medical Technologies and Protech Home Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Protech Home Medical00503.00

Protech Home Medical has a consensus price target of C$2.58, indicating a potential upside of 19.05%. Given Protech Home Medical's higher possible upside, analysts clearly believe Protech Home Medical is more favorable than Helius Medical Technologies.

Earnings & Valuation

This table compares Helius Medical Technologies and Protech Home Medical's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0077.27C$-27,269,800.00C($11.80)-1.87
Protech Home MedicalC$82.22 million2.98C$-5,417,568.00C($0.05)-45.21

Protech Home Medical has higher revenue and earnings than Helius Medical Technologies. Protech Home Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Helius Medical Technologies and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Protech Home Medical beats Helius Medical Technologies on 5 of the 7 factors compared between the two stocks.

Protech Home Medical (CVE:PHM) and Protech Home Medical (CVE:PTQ) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, risk, institutional ownership, dividends and valuation.

Earnings & Valuation

This table compares Protech Home Medical and Protech Home Medical's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50
Protech Home MedicalC$82.22 million2.98C$-5,417,568.00C($0.05)-45.21

Protech Home Medical has higher earnings, but lower revenue than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current ratings for Protech Home Medical and Protech Home Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Protech Home Medical0000N/A
Protech Home Medical00503.00

Protech Home Medical has a consensus price target of C$2.58, indicating a potential upside of 19.05%. Given Protech Home Medical's higher possible upside, analysts clearly believe Protech Home Medical is more favorable than Protech Home Medical.

Profitability

This table compares Protech Home Medical and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Protech Home MedicalN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Protech Home Medical beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.

Aurora Spine (CVE:ASG) and Protech Home Medical (CVE:PTQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, risk, earnings, valuation, institutional ownership and dividends.

Earnings and Valuation

This table compares Aurora Spine and Protech Home Medical's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora SpineC$8.84 million5.26C$-1,052,790.00C($0.02)-44.21
Protech Home MedicalC$82.22 million2.98C$-5,417,568.00C($0.05)-45.21

Aurora Spine has higher earnings, but lower revenue than Protech Home Medical. Protech Home Medical is trading at a lower price-to-earnings ratio than Aurora Spine, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations and price targets for Aurora Spine and Protech Home Medical, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Aurora Spine0000N/A
Protech Home Medical00503.00

Protech Home Medical has a consensus price target of C$2.58, indicating a potential upside of 19.05%. Given Protech Home Medical's higher possible upside, analysts clearly believe Protech Home Medical is more favorable than Aurora Spine.

Profitability

This table compares Aurora Spine and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Aurora SpineN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Summary

Aurora Spine beats Protech Home Medical on 4 of the 7 factors compared between the two stocks.


Protech Home Medical Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
VMD
Viemed Healthcare
0.3$12.51-1.4%C$494.92 millionC$131.31 million12.79
TMD
Titan Medical
0.8$2.13-1.4%C$233.29 millionC$20 million-5.90
Hamilton Thorne logo
HTL
Hamilton Thorne
1.2$1.70-2.9%C$165.83 millionC$38.36 million242.86High Trading Volume
Analyst Revision
HSM
Helius Medical Technologies
0.5$22.10-0.8%C$51.07 millionC$661,000.00-1.87Gap Up
PHM
Protech Home Medical
0.5$0.12-4.3%C$50.12 millionC$77.14 million57.50Gap Up
ASG
Aurora Spine
0.6$0.84-0.0%C$8.31 millionC$8.84 million-44.21Gap Up
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00Gap Up
ORTH
Ortho Regenerative Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
Smith & Nephew logo
SNN
Smith & Nephew
0.6N/AN/A$0.00N/A0.00
VMD
Viemed Healthcare
0.5$4.95-2.0%C$0.00N/A0.00Gap Up
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.